Fragment-based approach applied to the discovery of protein-protein interactions stabilisers

Dario Valenti, Stanimira Hristeva, Christian Ottmann, Anna Karawajczyk

Taros

Abstract:
Protein-protein interactions (PPIs) are constituents of numerous biological pathways and offer therapeutic intervention points into different pathologies such as cancer1, inflammation2, neurodegenerative3 and metabolic diseases4. Particularly, stabilisation of complexes showed to play a key role in biological pathways offering an additional access point to their modulation. Since this approach has not yet been explored in a systematic way, the TASPPI (TArgeted small-molecule Stabilisation of Protein-Protein Interactions) consortium5 aims to identify chemical PPI stabilisers in order to develop new crucial therapeutic strategies in the treatment of the disease areas mentioned above.

Want to know more about this publication?

Contact our scientists

medicinal chemistry

Drug Discovery

We are running our own state-of-the-art Drug Discovery Chemistry facilities in Germany with the option for process research chemistry, upscaling, kilolab production…

performance chemicals

Material Science

We create performance chemicals to enhance new materials, plastics, coatings, dyes & inks, cosmetics, flavors and many more research and industrial applications…

startseite-firstbanner

Looks interesting?

As a leading contract research organization in discovery chemistry and custom synthesis, Taros provides comprehensive solutions to meet our clients’ needs from diverse branches and applications

Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations, despite challenges, bridging very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project, starting from the development of synthetic routes to…

We will visit the BioJapan 2019, Asia's Premier Partnering Event for the Global Biotechnology Industry.